Abzena PLC (LSE:ABZA) - Share price


Stock Report

Abzena PLC ABZA

Last Price
£-

Day Change
-|-%

As of -
- | GBP
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap33.85Mil
52-Wk Range-
Yield %-
ISINGB00BN65QN46
Volume-
P/E-
P/S-
P/CF-

Share Price

Total Returns 11/10/2018

 Chg (%)  
More ...
Abzena PLC0.00 
FTSE 100 TR GBP-2.51
 
Financials
201620172018
More ...
Income Statement
Turnover9.8518.6521.95
Operating Profit-8.36-9.74-14.89
Net Profit-9.70-9.12-14.16
Reported EPS-9.00-7.00-7.00
Balance Sheet
Current Assets22.1111.2719.64
Non Current Assets27.3533.4934.65
Total Assets49.4644.7654.29
Current Liabilities5.856.326.90
Total Liabilities---
Total Equity41.0635.9343.69
Cash Flow
Operating Cash Flow-11.09-7.82-14.93
Net Change in Cash-2.08-9.592.65

Regulatory News

DateAuthor Headline
15/09/2016Emma Wall Henderson: Stocks We Wish We Hadn't Sold Post Brexit
Bronze Rated smaller companies investor Neil Hermon reveals the companies he regrets selling after the EU referendum - and those he was glad to pick up on the cheap
18/08/2016Karen Kwok Absolute Return Funds Fail to Deliver Despite £6bn Inflows
Investors continue to seek shelter in absolute return funds during market uncertainty, but some of those funds have lost investors money
31/05/2016Emma Wall Lloyds Bank Could Yield 8% by 2018, says Old Mutual
Bronze Rated Old Mutual fund manager Stephen Message picks three UK-listed dividend stocks for income investors

Company Profile

Abzena PLC is a healthcare company focused on the field of life sciences. It offers a range of complementary services and technologies for the selection, development, and manufacture of biopharmaceuticals. It offers biology, chemistry and manufacturing services to support the discovery and development of its customers' biopharmaceutical drug candidates. It derives maximum revenue from the provision of chemistry and biomanufacturing services. The group has business operations in the United Kingdom and other international countries.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 12/12/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-31.00
Op Mrgn-0.68
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, ChairmanDr. Kenneth Thomas Cunningham
Executive Director, Chief Financial Officer and Company SecretaryMr. Julian Matthew Smith
Non-Executive DirectorMr. Anthony David Brampton
Executive Director, Chief Executive OfficerDr. William John Edward Burt
Non-Executive DirectorPeter William Grant
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.